SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

AIM.A (AIM.A) News

Track canonical SquawkNews coverage tagged to AIM.A, AIM.A. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol AIM.A Asset market Sector Markets 90 days 1 Updated Sep 18, 2026, 12:32 PM UTC Open live news feed
L AIM ImmunoTech CEO Thomas K Equels acquires common shares worth $4,992 Thomas K. Equels, CEO, President, director, bought 24,000 AIM ImmunoTech common shares at $0.21 each. Direct holdings rose to 126,822 shares following the purchase. Disclaimer: This news brief was created by Public Techn REGULATION | Sep 18, 2026, 12:32 PM UTC